On 22 February, Royal Philips announced the global launch of Azurion, its innovative next generation image-guided therapy platform. Developed in collaboration with leading hospitals worldwide, the Azurion platform allows clinicians to easily and confidently perform a wide range of routine and complex procedures, helping them to optimise interventional lab performance and provide superior care. Philips Azurion forms the new core of its integrated solutions portfolio for the fast growing image-guided therapy market.
Parts of this platform were developed in the ITEA projects MEDIATE and BENEFIT. The MEDIATE project ran from September 2010 until December 2013 and was awarded with the ITEA Award of Excellence in the category ‘Business impact’ in 2015. A new architecture and the integration of multiple image and data sources were the core of this project and therewith it was an integral part of the development of the Azurion platform. In BENEFIT (July 2014 - December 2017), Philips is already working on new IT tools, which can be included in a next release of Azurion.